CRISPR Therapeutics SG&A Expense (Quarterly) Insights

CRISPR Therapeutics AG (CRSP)

54.28 +0.54 (+1.01%) USD | NASDAQ | Apr 26, 12:56

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	16.48M
September 30, 2023	18.29M
June 30, 2023	19.03M
March 31, 2023	22.36M
December 31, 2022	21.17M
September 30, 2022	27.00M
June 30, 2022	26.27M
March 31, 2022	28.02M
December 31, 2021	23.68M
September 30, 2021	23.71M
June 30, 2021	28.81M
March 31, 2021	24.52M
December 31, 2020	25.77M
September 30, 2020	21.54M
June 30, 2020	21.35M
March 31, 2020	19.55M
December 31, 2019	17.27M

Date	Value
September 30, 2019	15.52M
June 30, 2019	15.77M
March 31, 2019	14.93M
December 31, 2018	16.54M
September 30, 2018	10.18M
June 30, 2018	12.74M
March 31, 2018	8.836M
December 31, 2017	11.32M
September 30, 2017	8.112M
June 30, 2017	7.768M
March 31, 2017	8.642M
December 31, 2016	12.08M
September 30, 2016	4.107M
June 30, 2016	8.751M
March 31, 2016	6.116M
December 31, 2015	6.239M
September 30, 2015	2.453M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

15.52M

Minimum

Sep 2019

28.81M

Maximum

Jun 2021

21.90M

Average

21.54M

Median

Sep 2020

SG&A Expense (Quarterly) Benchmarks